NCT07433530

Brief Summary

Purpose: To compare hemodynamic effects of two different modes of ventilation (volume-controlled and pressure-controlled volume guaranteed) in patients undergoing laparoscopic gynecology surgeries with exaggerated Trendelenburg position. Methods: Thirty patients undergoing laparoscopic gynecology operations were ventilated using either volume-controlled (Group VC) or pressure-controlled volume guaranteed mode (Group PCVG) (n = 15 for both groups). Hemodynamic variables were measured using Pressure Recording Analytical Method by radial artery cannulation in addition to peak and mean airway pressures and expired tidal volume.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 8, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 6, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 7, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

February 16, 2026

Last Update Submit

February 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac Index (CI)

    Change in Cardiac Index

    Measured after induction of anesthesia, 10 minutes after pneumoperitoneum, 1 hour after pneumoperitoneum, after desufflation, and after extubation.

Study Arms (2)

Lung Protective Ventilation

EXPERIMENTAL

Patients in this group received lung-protective ventilation consisting of a tidal volume of 6 mL/kg predicted body weight, positive end-expiratory pressure (PEEP) of 5-8 cmH₂O, and periodic recruitment maneuvers performed every 30 minutes during surgery.

Procedure: Lung Protective Ventilation

Standard Ventilation

ACTIVE COMPARATOR

Patients in this group received conventional mechanical ventilation with a tidal volume of 8-10 mL/kg predicted body weight and low PEEP (0-2 cmH₂O) without routine recruitment maneuvers.

Procedure: Lung Protective Ventilation

Interventions

? Intervention 1 Lung Protective Ventilation Intervention Description: Patients were ventilated using a lung-protective mechanical ventilation strategy with tidal volume of 6-8 mL/kg of ideal body weight, PEEP of 5-10 cmH₂O, plateau pressure \<30 cmH₂O, and driving pressure \<15 cmH₂O. Respiratory rate was adjusted to maintain PaCO₂ between 35-45 mmHg. Recruitment maneuvers (30-40 cmH₂O for 10-15 seconds) were applied when clinically indicated.? Intervention 2 Standard Ventilation Intervention Description: Patients were ventilated using a conventional mechanical ventilation strategy with tidal volume of 10-12 mL/kg of ideal body weight and PEEP of 0-2 cmH₂O. Respiratory rate was adjusted to maintain PaCO₂ between 35-45 mmHg.

Also known as: Standart ventilation
Lung Protective VentilationStandard Ventilation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 70 years
  • ASA physical status I-III
  • Scheduled for elective laparoscopic nephrectomy
  • Ability to provide written informed consent

You may not qualify if:

  • Emergency surgery
  • Hemodynamic instability
  • Severe cardiac disease (including significant valvular disease or uncontrolled arrhythmia)
  • Endocrine disorders affecting hemodynamic status
  • Hemoglobin \< 10 g/dL
  • Known coagulation disorders
  • Ongoing anticoagulant therapy
  • Severe peripheral arterial disease
  • History of cerebrovascular accident
  • Pregnancy
  • Advanced hepatic failure
  • Advanced renal failure
  • Body mass index (BMI) \> 35 kg/m²
  • Conversion from laparoscopic to open surgery
  • Inability to maintain arterial catheterization
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elzem Sen

Gaziantep, Sehitkamil, 5327842151, Turkey (Türkiye)

Location

Study Officials

  • Elzem Sen, Assoc Prof

    University of Gaziantep

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the intervention, the anesthesiology team administering the ventilation strategy was aware of group allocation. Patients were under general anesthesia during the intervention. Advanced hemodynamic parameters were recorded objectively using the PRAM monitoring system. Therefore, the study was conducted as an open-label trial without masking.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 25, 2026

Study Start

April 8, 2025

Primary Completion

November 6, 2025

Study Completion

November 7, 2025

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations